Generation Bio Co (GBIO)

• $2.97

  $3.27

  $3.06
  

  3.1%

  Downside

  Day's Volatility :9.33%

  Upside

  6.42%

  
• $0.86

  $6.98

  $3.06
  

  71.9%

  Downside

  52 Weeks Volatility :87.68%

  Upside

  56.16%

  

Returns

What analysts predicted

Upside of 145.1%

• T. Rowe Price Associates, Inc.

  13.35%

• FMR Inc

  8.02%

• Bellevue Group AG

  5.80%

• BlackRock Inc

  4.58%

• Bank of America Corp

  4.49%

• Artal Group S A

  4.23%

generation bio is creating a revolutionary new class of genetic medicines that deliver durable, high levels of gene expression and have drug-like properties, including ability to titrate to effect and re-dose. our unique genewave technology allows us to overcome the limitations of other approaches by delivering larger genes, including more sophisticated regulatory elements, and avoiding the immunogenicity which limits both the number of patients who can be treated and the ability to re-dose them over time. we are a community of creative problem-solvers and independent thinkers. we are guided by strong personal integrity, humility, and the collaborative, learning mindset required to create solutions for patients and their families. to learn more about our efforts to usher in a new generation in medicine, please visit www.generationbio.com or our twitter feed, @lifetimegenetx.